etoposide has been researched along with leucinol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ann, J; Cho, D; Kim, JH; Kim, S; Kim, SE; Kim, WK; Lee, J; Lee, S; Yoon, I; Yoon, S; Zuo, D | 1 |
| Ann, J; Byun, WS; Kim, C; Kim, JH; Kim, S; Kim, SE; Lee, J; Lee, S; Tran, PT; Yoon, I; Yoon, S | 1 |
2 other study(ies) available for etoposide and leucinol
| Article | Year |
|---|---|
Discovery of novel leucyladenylate sulfamate surrogates as leucyl-tRNA synthetase (LRS)-targeted mammalian target of rapamycin complex 1 (mTORC1) inhibitors.
Topics: Antineoplastic Agents; Cell Line; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Leucine; Leucine-tRNA Ligase; Mechanistic Target of Rapamycin Complex 1; Molecular Structure; Structure-Activity Relationship | 2018 |
Structure-activity relationship of leucyladenylate sulfamate analogues as leucyl-tRNA synthetase (LRS)-targeting inhibitors of Mammalian target of rapamycin complex 1 (mTORC1).
Topics: Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; HEK293 Cells; Humans; Leucine; Leucine-tRNA Ligase; Mechanistic Target of Rapamycin Complex 1; Neoplasms; Signal Transduction; Structure-Activity Relationship | 2019 |